IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.48M	$42.69M	-
Other	Geffner Michael	218.0K	$6.31M	-
Other	Stout Jay S	199.7K	$5.78M	-
COO	Gloria Melanie	175.9K	$5.09M	-
Other	Van Tuyl Christopher	152.2K	$4.41M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 1, 2026	Susman Robert Graham	Director	Sell	2,502	$27.17	$67,979.34	-6.4%	-	-
Jan 7, 2026	Stout Jay S63	Chief Technology Officer	Sell	1,203	$26.53	$31,914.08	-0.3%	-7.9%	-
Dec 18, 2025	Van Tuyl Christopher	Chief Legal Officer	Sell	10,813	$26.91	$290,942.54	-3.5%	-9.9%	-
Dec 1, 2025	Hughes Douglas J.	Director	Sell	15,000	$23.24	$348,665.38	-5.8%	+22.0%	-
Dec 1, 2025	Fromkin Andrew J.45	Director	Sell	22,249	$23.25	$517,189.24	-11.3%	+22.0%	-
Nov 20, 2025	Gloria Melanie	Chief Operating Officer	Sell	12,626	$23.62	$298,237.29	-3.5%	+16.9%	-
Oct 22, 2025	Geffner Michael66	Chief Medical Officer	Sell	2,595	$19.03	$49,382.85	-1.2%	+38.3%	-
Oct 22, 2025	Stout Jay S63	Chief Technology Officer	Sell	2,520	$19.03	$47,955.60	-1.2%	+38.3%	-
Oct 8, 2025	Geffner Michael66	Chief Medical Officer	Sell	1,272	$16.30	$20,733.60	-0.6%	+61.1%	-
Oct 8, 2025	Stout Jay S63	Chief Technology Officer	Sell	1,585	$16.30	$25,835.50	-0.8%	+61.1%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC